1
|
Schwartz R, Zev S, Major DT. Differential Substrate Sensing in Terpene Synthases from Plants and Microorganisms: Insight from Structural, Bioinformatic, and EnzyDock Analyses. Angew Chem Int Ed Engl 2024:e202400743. [PMID: 38556463 DOI: 10.1002/anie.202400743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2024] [Revised: 03/26/2024] [Accepted: 03/26/2024] [Indexed: 04/02/2024]
Abstract
Terpene synthases (TPSs) catalyze the first step in the formation of terpenoids, which comprise the largest class of natural products in nature. TPSs employ a family of universal natural substrates, composed of isoprenoid units bound to a diphosphate moiety. The intricate structures generated by TPSs are the result of substrate binding and folding in the active site, enzyme-controlled carbocation reaction cascades, and final reaction quenching. A key unaddressed question in class I TPSs is the asymmetric nature of the diphosphate-(Mg2+)3 cluster, which forms a critical part of the active site. In this asymmetric ion cluster, two diphosphate oxygen atoms protrude into the active site pocket. The substrate hydrocarbon tail, which is eventually molded into terpenes, can bind to either of these oxygen atoms, yet to which is unknown. Herein, we employ structural, bioinformatics, and EnzyDock docking tools to address this enigma. We bring initial data suggesting that this difference is rooted in evolutionary differences between TPSs. We hypothesize that this alteration in binding, and subsequent chemistry, is due to TPSs originating from plants or microorganisms. We further suggest that this difference can cast light on the frequent observation that the chiral products or intermediates of plant and bacterial terpene synthases represent opposite enantiomers.
Collapse
Affiliation(s)
- Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan, 52900, Israel
| | - Shani Zev
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan, 52900, Israel
| | - Dan T Major
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan, 52900, Israel
| |
Collapse
|
2
|
Pienkowski M, Chaiton M, Bondy SJ, Cohen JE, Dubray J, Eissenberg T, Kaufman P, Stanbrook MB, O'Loughlin J, Dos Santos J, Schwartz R. Milestones in the natural course of the onset of e-cigarette dependence among adolescents and young adults: Retrospective study. Addict Behav 2024; 148:107846. [PMID: 37678007 DOI: 10.1016/j.addbeh.2023.107846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2023] [Revised: 08/24/2023] [Accepted: 08/30/2023] [Indexed: 09/09/2023]
Abstract
INTRODUCTION There is considerable controversy about the development of dependence among e-cigarette users. This study describes the average amount of time using e-cigarettes before dependence milestones emerge and the differences in developing dependence between e-cigarette users who smoke cigarettes compared to those who do not. METHODS Adolescents and young adults aged 16-25 living in Canada were recruited into an online survey in 2021. Current (past-month) e-cigarette users completed 15 items assessing dependence from the Penn-State Electronic Cigarette Dependence Index and the E-cigarette Dependence Scale for a total of 12 behavioural (e.g., difficulty refraining from vaping) and 3 frequency (e.g., using e-cigarette daily, weekly, or monthly) indicators of dependence milestones. Number of years after e-cigarette onset at which the cumulative probability of attaining each milestone was 25 % was computed. RESULTS Among 1205 participants, most (80.6 %) were female, 73.7 % were Caucasian, and 49.7 % resided in Ontario. Ten of the 12 e-cigarette use milestones were attained by 25 % of respondents 2 years after starting vaping except for daily cigarette use (2.5 years after onset) and waking at night to vape (5.6 years after onset). Within the entire study population, frequency milestones (weekly, monthly, daily e-cigarette use) were attained faster by ever-smokers (hazard ratio compared to attainment by never-smokers: 1.12, 1.21, and 1.28 respectively), whereas for at least monthly users, behavioural milestones were attained faster by never-smokers. DISCUSSION Many current e-cigarette users developed symptoms of e-cigarette dependence between two and five years since onset. Never smokers may be at higher risk of becoming e-cigarette dependent since they attained e-cigarette dependence milestones faster than smokers.
Collapse
Affiliation(s)
- M Pienkowski
- Dalla Lana School of Public Health, University of Toronto, Canada
| | - M Chaiton
- Dalla Lana School of Public Health, University of Toronto, Canada; Centre for Addiction and Mental Health, Toronto, Canada.
| | - S J Bondy
- Dalla Lana School of Public Health, University of Toronto, Canada
| | - J E Cohen
- Dalla Lana School of Public Health, University of Toronto, Canada; Institute for Global Tobacco Control, Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - J Dubray
- Dalla Lana School of Public Health, University of Toronto, Canada
| | - T Eissenberg
- Center for the Study of Tobacco Products, Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA
| | - P Kaufman
- Dalla Lana School of Public Health, University of Toronto, Canada
| | - M B Stanbrook
- Division of Respirology, Department of Medicine, University of Toronto, Canada
| | - J O'Loughlin
- School of Public Health, University of Montreal, Montreal, QC, Canada
| | - J Dos Santos
- Dalla Lana School of Public Health, University of Toronto, Canada
| | - R Schwartz
- Dalla Lana School of Public Health, University of Toronto, Canada; Centre for Addiction and Mental Health, Toronto, Canada
| |
Collapse
|
3
|
Witek TJ, Abolhassani F, Schwartz R, Oh J. A "Tail" of three cities. Public health and acute atrophy of vigilance. Public Health 2023; 223:e12-e13. [PMID: 36907746 PMCID: PMC10002669 DOI: 10.1016/j.puhe.2023.01.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2023] [Revised: 01/20/2023] [Accepted: 01/27/2023] [Indexed: 03/12/2023]
Affiliation(s)
- T J Witek
- Institute of Health Policy Management & Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario Canada.
| | | | - R Schwartz
- Institute of Health Policy Management & Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario Canada
| | - J Oh
- Seoul National University College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
4
|
Schwartz R, Ruthstein S, Major DT. Copper coordination states affect the flexibility of copper Metallochaperone Atox1: Insights from molecular dynamics simulations. Protein Sci 2022; 31:e4464. [PMID: 36208051 PMCID: PMC9667823 DOI: 10.1002/pro.4464] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2022] [Revised: 09/15/2022] [Accepted: 10/04/2022] [Indexed: 12/13/2022]
Abstract
Copper is an essential element in nature but in excess, it is toxic to the living cell. The human metallochaperone Atox1 participates in copper homeostasis and is responsible for copper transmission. In a previous multiscale simulation study, we noticed a change in the coordination state of the Cu(I) ion, from 4 bound cysteine residues to 3, in agreement with earlier studies. Here, we perform and analyze classical molecular dynamic simulations of various coordination states: 2, 3, and 4. The main observation is an increase in protein flexibility as a result of a decrease in the coordination state. In addition, we identified several populated conformations that correlate well with double electron-electron resonance distance distributions or an X-ray structure of Cu(I)-bound Atox1. We suggest that the increased flexibility might benefit the process of ion transmission between interacting proteins. Further experiments can scrutinize this hypothesis and shed additional light on the mechanism of action of Atox1.
Collapse
Affiliation(s)
- Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology and Advanced MaterialsBar‐Ilan UniversityRamat‐GanIsrael
| | - Sharon Ruthstein
- Department of Chemistry and Institute for Nanotechnology and Advanced MaterialsBar‐Ilan UniversityRamat‐GanIsrael
| | - Dan Thomas Major
- Department of Chemistry and Institute for Nanotechnology and Advanced MaterialsBar‐Ilan UniversityRamat‐GanIsrael
| |
Collapse
|
5
|
Kolin G, Schwartz R, Shuster D, Major DT, Hoz S. Cooperative Intrinsic Basicity and Hydrogen Bonding Render SmI 2 More Azaphilic than Oxophilic. ACS Omega 2022; 7:40021-40024. [PMID: 36385862 PMCID: PMC9647864 DOI: 10.1021/acsomega.2c04680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/25/2022] [Accepted: 09/05/2022] [Indexed: 06/16/2023]
Abstract
It has been recently shown that SmI2 is more azaphilic than oxophilic. Density functional theory calculations reveal that coordination of 1-3 molecules of ethylenediamine is more exothermic by up to 10 kcal/mol than coordination of the corresponding number of ethylene glycol molecules. Taking into account also hydrogen bonds between ligands and tetrahydrofuran doubles this preference. The intrinsic affinity parallels the order of basicity. The cooperativity with the hydrogen bonding makes SmI2 more azaphilic than oxophilic.
Collapse
|
6
|
Tan ACS, Schwartz R, Anaya D, Chatziralli I, Yuan M, Cicinelli MV, Faes L, Mustapha M, Phasukkijwatana N, Pohlmann D, Reynolds R, Rosenblatt A, Savastano A, Touhami S, Vaezi K, Ventura CV, Vogt D, Ambati J, de Smet MD, Loewenstein A. Are intravitreal injections essential during the COVID-19 pandemic? Global preferred practice patterns and practical recommendations. Int J Retina Vitreous 2022; 8:33. [PMID: 35672810 PMCID: PMC9171474 DOI: 10.1186/s40942-022-00380-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2021] [Accepted: 05/01/2022] [Indexed: 11/12/2022] Open
Abstract
Tertiary outpatient ophthalmology clinics are high-risk environments for COVID-19 transmission, especially retina clinics, where regular follow-up is needed for elderly patients with multiple comorbidities. Intravitreal injection therapy (IVT) for chronic macular diseases, is one of the most common procedures performed, associated with a significant burden of care because of the vigorous treatment regimen associated with multiple investigations. While minimizing the risk of COVID-19 infection transmission is a priority, this must be balanced against the continued provision of sight-saving ophthalmic care to patients at risk of permanent vision loss. This review aims to give evidence-based guidelines on managing IVT during the COVID-19 pandemic in common macular diseases such as age-related macular degeneration, diabetic macula edema and retinal vascular disease and to report on how the COVID-19 pandemic has affected IVT practices worldwide. To illustrate some real-world examples, 18 participants in the International Retina Collaborative, from 15 countries and across four continents, were surveyed regarding pre- and during- COVID-19 pandemic IVT practices in tertiary ophthalmic centers. The majority of centers reported a reduction in the number of appointments to reduce the risk of the spread of COVID-19 with varying changes to their IVT regimen to treat various macula diseases. Due to the constantly evolving nature of the COVID-19 pandemic, and the uncertainty about the normal resumption of health services, we suggest that new solutions for eye healthcare provision, like telemedicine, may be adopted in the future when we consider new long-term adaptations required to cope with the COVID-19 pandemic.
Collapse
Affiliation(s)
- A C S Tan
- Singapore National Eye Centre, Singapore, Singapore. .,Singapore Eye Research Institute, Singapore, Singapore. .,Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.
| | - R Schwartz
- Moorfields Eye Hospital NHS Foundation Trust, London, UK
| | - D Anaya
- Department of Retina, Clínica de Oftalmología de Cali, Valle del Cauca, Colombia
| | - I Chatziralli
- 2nd Department of Ophthalmology, National and Kapodistrian University of Athens, Athens, Greece
| | - M Yuan
- Department of Retina, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China
| | - M V Cicinelli
- School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.,Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - L Faes
- Moorfields Eye Hospital NHS Foundation Trust, London, UK.,Cantonal Hospital Lucerne, Lucerne, Switzerland
| | - M Mustapha
- Department of Ophthalmology, Universiti Kebangsaan Malaysia, Kulala Lumpur, Malaysia
| | - N Phasukkijwatana
- Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - D Pohlmann
- Charité - Universitätsmedizin Berlin, FreieUiversität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
| | - R Reynolds
- Department of Ophthalmology, Aneurin Bevan University Health Board, Wales, UK
| | - A Rosenblatt
- Department of Ophthalmology, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
| | - A Savastano
- Ophthalmology Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.,Università Cattolica del Sacro Cuore, Rome, Italy
| | - S Touhami
- Department of Ophthalmology, Reference Center in Rare diseases, DHU Sight Restore, Hôpital Pitié Salpêtrière, Sorbonne Université, 47-83 Boulevard de l'Hôpital, 75013, Paris, France
| | - K Vaezi
- Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, Canada
| | - C V Ventura
- Department of Ophthalmology, Altino Ventura Foundation (FAV), Recife, Brazil.,Department of Ophthalmology, HOPE Eye Hospital, Recife, Brazil
| | - D Vogt
- Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
| | - J Ambati
- Center for Advanced Vision Science, Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville, USA
| | - M D de Smet
- Department of Ophthalmology, Leiden University, Leiden, The Netherlands.,MIOS sa, Lausanne, Switzerland
| | - A Loewenstein
- Department of Ophthalmology, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
| | | |
Collapse
|
7
|
Schwartz R, Fonacier L, Shroff P. M302 CHALLENGING DIAGNOSIS OF CONTACT DERMATITIS TO PERIPHERAL IV AND PHLEBOTOMY IN PREGNANCY. Ann Allergy Asthma Immunol 2021. [DOI: 10.1016/j.anai.2021.08.401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
8
|
Kempf M, Schubert A, Schwartz R, Korn T. Two-color Kerr microscopy of two-dimensional materials with sub-picosecond time resolution. Rev Sci Instrum 2021; 92:113904. [PMID: 34852534 DOI: 10.1063/5.0058110] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/27/2021] [Accepted: 10/12/2021] [Indexed: 06/13/2023]
Abstract
We present a two-color Kerr microscopy system based on two electronically synchronized erbium-fiber laser oscillators with independently tunable emission energies spanning most of the visible spectrum. Combining a spatial resolution below 2 μm and sub-ps time resolution with high sensitivity and cryogenic sample temperatures, it is ideally suited for studying spin and valley dynamics in a wide range of two-dimensional materials. We illustrate its capabilities by studying a monolayer of the common semiconducting transition metal disulfide MoS2.
Collapse
Affiliation(s)
- M Kempf
- Institute of Physics, University of Rostock, 18059 Rostock, Germany
| | - A Schubert
- Institute of Physics, University of Rostock, 18059 Rostock, Germany
| | - R Schwartz
- Institute of Physics, University of Rostock, 18059 Rostock, Germany
| | - T Korn
- Institute of Physics, University of Rostock, 18059 Rostock, Germany
| |
Collapse
|
9
|
Schwartz R, Ruthstein S, Major DT. Molecular Dynamics Simulations of the Apo and Holo States of the Copper Binding Protein CueR Reveal Principal Bending and Twisting Motions. J Phys Chem B 2021; 125:9417-9425. [PMID: 34384216 DOI: 10.1021/acs.jpcb.1c02553] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Copper is essential for proper functioning of cells but is dangerous in unregulated concentrations. One of the members in the bacterial system responsible for facilitating copper homeostasis is the copper efflux regulator (CueR) protein. Upon copper binding, CueR induces transcription of additional copper homeostasis proteins via a cascade of events. There are some available crystal structures of CueR, in the holo (copper-bound), active (copper- and DNA-bound), and repressed (only DNA-bound) states, and these structures suggest that transcription initiation involves a distortion in the promoter DNA strand. In this work, we study the dynamic behavior of the protein, using molecular dynamics simulations, and compare with available electron paramagnetic resonance measurements for validation. We develop simple force-field parameters to describe the copper-binding motif, thus enabling the use of simplified, classical physics equations. This enabled us to access reasonable simulation times that illustrate global motions of the protein. Both in the holo and apo states of CueR, we observed large-scale helical bending motions that could be involved in the bending of a bound DNA molecule so that transcription activation can take place. Additionally, copper binding might afford increased rigidification of the active state via helix α6.
Collapse
Affiliation(s)
- Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 5290002, Israel
| | - Sharon Ruthstein
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 5290002, Israel
| | - Dan Thomas Major
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 5290002, Israel
| |
Collapse
|
10
|
Zev S, Raz K, Schwartz R, Tarabeh R, Gupta PK, Major DT. Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro. J Chem Inf Model 2021. [DOI: 10.1021/acs.jcim.1c00263 order by 1-- #] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Affiliation(s)
- Shani Zev
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Keren Raz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Reem Tarabeh
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Prashant Kumar Gupta
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Dan T. Major
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| |
Collapse
|
11
|
Zev S, Raz K, Schwartz R, Tarabeh R, Gupta PK, Major DT. Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro. J Chem Inf Model 2021. [DOI: 10.1021/acs.jcim.1c00263 order by 8029-- awyx] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Affiliation(s)
- Shani Zev
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Keren Raz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Reem Tarabeh
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Prashant Kumar Gupta
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Dan T. Major
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| |
Collapse
|
12
|
Zev S, Raz K, Schwartz R, Tarabeh R, Gupta PK, Major DT. Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro. J Chem Inf Model 2021. [DOI: 10.1021/acs.jcim.1c00263 order by 1-- -] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Affiliation(s)
- Shani Zev
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Keren Raz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Reem Tarabeh
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Prashant Kumar Gupta
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Dan T. Major
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| |
Collapse
|
13
|
Zev S, Raz K, Schwartz R, Tarabeh R, Gupta PK, Major DT. Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro. J Chem Inf Model 2021. [DOI: 10.1021/acs.jcim.1c00263 order by 8029-- -] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Affiliation(s)
- Shani Zev
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Keren Raz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Reem Tarabeh
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Prashant Kumar Gupta
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Dan T. Major
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| |
Collapse
|
14
|
Zev S, Raz K, Schwartz R, Tarabeh R, Gupta PK, Major DT. Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro. J Chem Inf Model 2021. [DOI: 10.1021/acs.jcim.1c00263 order by 8029-- #] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Affiliation(s)
- Shani Zev
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Keren Raz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Reem Tarabeh
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Prashant Kumar Gupta
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Dan T. Major
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| |
Collapse
|
15
|
Zev S, Raz K, Schwartz R, Tarabeh R, Gupta PK, Major DT. Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro. J Chem Inf Model 2021. [DOI: 10.1021/acs.jcim.1c00263 and 1880=1880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Affiliation(s)
- Shani Zev
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Keren Raz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Reem Tarabeh
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Prashant Kumar Gupta
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Dan T. Major
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| |
Collapse
|
16
|
Zev S, Raz K, Schwartz R, Tarabeh R, Gupta PK, Major DT. Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro. J Chem Inf Model 2021. [DOI: 10.1021/acs.jcim.1c00263 order by 1-- gadu] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Affiliation(s)
- Shani Zev
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Keren Raz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Reem Tarabeh
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Prashant Kumar Gupta
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Dan T. Major
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| |
Collapse
|
17
|
Zev S, Raz K, Schwartz R, Tarabeh R, Gupta PK, Major DT. Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro. J Chem Inf Model 2021; 61:2957-2966. [PMID: 34047191 PMCID: PMC8189035 DOI: 10.1021/acs.jcim.1c00263] [Citation(s) in RCA: 37] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2021] [Indexed: 12/14/2022]
Abstract
The coronavirus SARS-CoV-2 main protease, Mpro, is conserved among coronaviruses with no human homolog and has therefore attracted significant attention as an enzyme drug target for COVID-19. The number of studies targeting Mpro for in silico screening has grown rapidly, and it would be of great interest to know in advance how well docking methods can reproduce the correct ligand binding modes and rank these correctly. Clearly, current attempts at designing drugs targeting Mpro with the aid of computational docking would benefit from a priori knowledge of the ability of docking programs to predict correct binding modes and score these correctly. In the current work, we tested the ability of several leading docking programs, namely, Glide, DOCK, AutoDock, AutoDock Vina, FRED, and EnzyDock, to correctly identify and score the binding mode of Mpro ligands in 193 crystal structures. None of the codes were able to correctly identify the crystal structure binding mode (lowest energy pose with root-mean-square deviation < 2 Å) in more than 26% of the cases for noncovalently bound ligands (Glide: top performer), whereas for covalently bound ligands the top score was 45% (EnzyDock). These results suggest that one should perform in silico campaigns of Mpro with care and that more comprehensive strategies including ligand free energy perturbation might be necessary in conjunction with virtual screening and docking.
Collapse
Affiliation(s)
- Shani Zev
- Department of Chemistry and Institute for Nanotechnology
& Advanced Materials, Bar-Ilan University, Ramat-Gan 52900,
Israel
| | - Keren Raz
- Department of Chemistry and Institute for Nanotechnology
& Advanced Materials, Bar-Ilan University, Ramat-Gan 52900,
Israel
| | - Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology
& Advanced Materials, Bar-Ilan University, Ramat-Gan 52900,
Israel
| | - Reem Tarabeh
- Department of Chemistry and Institute for Nanotechnology
& Advanced Materials, Bar-Ilan University, Ramat-Gan 52900,
Israel
| | - Prashant Kumar Gupta
- Department of Chemistry and Institute for Nanotechnology
& Advanced Materials, Bar-Ilan University, Ramat-Gan 52900,
Israel
| | - Dan T. Major
- Department of Chemistry and Institute for Nanotechnology
& Advanced Materials, Bar-Ilan University, Ramat-Gan 52900,
Israel
| |
Collapse
|
18
|
|
19
|
Perkal O, Qasem Z, Turgeman M, Schwartz R, Gevorkyan-Airapetov L, Pavlin M, Magistrato A, Major DT, Ruthstein S. Cu(I) Controls Conformational States in Human Atox1 Metallochaperone: An EPR and Multiscale Simulation Study. J Phys Chem B 2020; 124:4399-4411. [PMID: 32396355 PMCID: PMC7294806 DOI: 10.1021/acs.jpcb.0c01744] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
![]()
Atox1 is a human
copper metallochaperone that is responsible for
transferring copper ions from the main human copper transporter, hCtr1,
to ATP7A/B in the Golgi apparatus. Atox1 interacts with the Ctr1 C-terminal
domain as a dimer, although it transfers the copper ions to ATP7A/B
in a monomeric form. The copper binding site in the Atox1 dimer involves
Cys12 and Cys15, while Lys60 was also suggested to play a role in
the copper binding. We recently showed that Atox1 can adopt various
conformational states, depending on the interacting protein. In the
current study, we apply EPR experiments together with hybrid quantum
mechanics–molecular mechanics molecular dynamics simulations
using a recently developed semiempirical density functional theory
approach, to better understand the effect of Atox1’s conformational
states on copper coordination. We propose that the flexibility of
Atox1 occurs owing to protonation of one or more of the cysteine residues,
and that Cys15 is an important residue for Atox1 dimerization, while
Cys12 is a critical residue for Cu(I) binding. We also show that Lys60
electrostatically stabilizes the Cu(I)–Atox1 dimer.
Collapse
Affiliation(s)
- Ortal Perkal
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Zena Qasem
- Department of Chemistry, Faculty of Exact Sciences, Bar Ilan University, Ramat-Gan 5290002, Israel
| | - Meital Turgeman
- Department of Chemistry, Faculty of Exact Sciences, Bar Ilan University, Ramat-Gan 5290002, Israel
| | - Renana Schwartz
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Lada Gevorkyan-Airapetov
- Department of Chemistry, Faculty of Exact Sciences, Bar Ilan University, Ramat-Gan 5290002, Israel
| | - Matic Pavlin
- CNR-IOM at SISSA, via Bonomea 265, 34135, Trieste, Italy
| | | | - Dan Thomas Major
- Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - Sharon Ruthstein
- Department of Chemistry, Faculty of Exact Sciences, Bar Ilan University, Ramat-Gan 5290002, Israel
| |
Collapse
|
20
|
Fevrier E, Yip R, Taioli E, Becker B, Henschke C, Schwartz R. P2.16-03 IELCART Quality of Life in the First Year After Surgery for Stage IA Lung Cancer Patients: Preliminary Results. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
21
|
Lin J, Ma Y, Schwartz R, Woodbury D, Nees JA, Mathis M, Thomas AGR, Krushelnick K, Milchberg H. Adaptive control of laser-wakefield accelerators driven by mid-IR laser pulses. Opt Express 2019; 27:10912-10923. [PMID: 31052944 DOI: 10.1364/oe.27.010912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/21/2019] [Accepted: 03/16/2019] [Indexed: 06/09/2023]
Abstract
There has been growing interest both in studying high intensity ultrafast laser plasma interactions with adaptive control systems as well as using long wavelength driver beams. We demonstrate the coherent control of the dynamics of laser-wakefield acceleration driven by ultrashort (∼ 100 fs) mid-infrared (∼ 3.9 μm) laser pulses. The critical density at this wavelength is 7.3 × 1019 cm-3, which is achievable with an ordinary gas target system. Interactions between mid-infrared laser pulses and such near-critical-density plasma may be beneficial due to much higher absorption of laser energy. In addition, the normalized vector potential of the laser field a0 increases with longer laser wavelength, lowering the required peak laser intensity to drive non-linear laser-wakefield acceleration. Here, MeV level, collimated electron beams with non-thermal, peaked energy spectra are generated. Optimization of electron beam qualities are realized through adaptive control of the laser wavefront. A genetic algorithm controlling a deformable mirror improves the electron total charge, energy spectra, beam pointing and stability at various plasma density profiles. Particle-in-cell simulations reveal that the optimal wavefront causes an earlier injection on the density up-ramp and thus higher energy gain as well as less filamentation during the interaction, which leads to the improvement in electron beam collimation and energy spectra.
Collapse
|
22
|
Ornstein K, Liu B, Alpert N, Taioli E, Schwartz R. NEW CANCER DIAGNOSES AMONG OLDER MEDICARE BENEFICIARIES. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.533] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | - B Liu
- Icahn School of Medicine at Mount Sinai
| | - N Alpert
- Icahn School of Medicine at Mount Sinai
| | - E Taioli
- Icahn School of Medicine at Mount Sinai
| | | |
Collapse
|
23
|
Schwartz R, Trivedi R, Lorenz K, Zulman D. NEUROLOGIST STRATEGIES FOR OPTIMIZING THE PARKINSON’S DISEASE CLINICAL ENCOUNTER. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.1856] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- R Schwartz
- VA Palo Alto Health Care System & Stanford School of Medicine
| | | | | | - D Zulman
- Stanford University School of Medicine
| |
Collapse
|
24
|
Schwartz R, Zulman D, Gray C, Trivedi R. “IT’S A DISEASE OF FAMILIES”: NEUROLOGISTS’ INSIGHTS ON HOW PARKINSON’S DISEASE AFFECTS FAMILY DYNAMICS. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- R Schwartz
- VA Palo Alto Health Care System & Stanford School of Medicine
| | - D Zulman
- Stanford University School of Medicine
| | - C Gray
- VA Palo Alto Health Care System
| | | |
Collapse
|
25
|
Lieberman-Cribbin W, Wolf A, Schwartz R, Flores R, Taioli E. MA12.02 Quality of Life Following Pleurectomy Decortication and Extrapleural Pneumonectomy for Pleural Malignant Mesothelioma. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
26
|
Tuminello S, Wisnivesky J, Schwartz R, Liu B, Mhango G, Flores R, Taioli E. MA01.05 Opioids and Sleep Medication Use After Surgery for Early Stage Lung Cancer: A SEER-Medicare Analysis. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
27
|
Woodbury D, Feder L, Shumakova V, Gollner C, Schwartz R, Miao B, Salehi F, Korolov A, Pugžlys A, Baltuška A, Milchberg HM. Laser wakefield acceleration with mid-IR laser pulses. Opt Lett 2018; 43:1131-1134. [PMID: 29489797 DOI: 10.1364/ol.43.001131] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/16/2018] [Accepted: 01/30/2018] [Indexed: 06/08/2023]
Abstract
We report on, to the best of our knowledge, the first results of laser plasma wakefield acceleration driven by ultrashort mid-infrared (IR) laser pulses (λ=3.9 μm, 100 fs, 0.25 TW), which enable near- and above-critical density interactions with moderate-density gas jets. Relativistic electron acceleration up to ∼12 MeV occurs when the jet width exceeds the threshold scale length for relativistic self-focusing. We present scaling trends in the accelerated beam profiles, charge, and spectra, which are supported by particle-in-cell simulations and time-resolved images of the interaction. For similarly scaled conditions, we observe significant increases in the accelerated charge, compared to previous experiments with near-infrared (λ=800 nm) pulses.
Collapse
|
28
|
Flores R, Taioli E, Yankelevitz D, Yip R, Becker B, Jirapatnakul A, Reeves A, Schwartz R, Tam K, Henschke C. P2.16-022 Initiative for Early Lung Cancer Research on Treatment: Pilot Implementation. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
29
|
Furniss G, Opel A, Hussein A, Pearman C, Grace A, Connelly D, Orlowski A, Banerjee A, McNicholas T, Providencia R, Montañes M, Providencia R, Panagopoulos D, Tomlinson D, Dalrymple-Hay M, Haywood G, Butler A, Ang R, Ullah W, Schwartz R, Fannon M, Finlay M, Hunter R, Schilling R, Das M, Asfour I, Morgan M, Ronayne C, Shaw M, Snowdon R, Gupta D, Todd D, King R, Hall M, Modi S, Mediratta N, Gupta D, Reddy V, Neuzil P, Willems S, Verma A, Heck P, Schilling R, Lambiase P, Hall M, Nicholl B, McQueenie R, Jani BD, McKeag N, Gallacher K, Mair F, Heaton D, Macdonald J, Burnell J, Ryan R, Marshall T, Sutton C, O'Callaghan S, Kenny R, Karim N, Srinivasan N, Ferreira M, Goncalves L, Lambiase P, Toledano M, Field E, Walsh H, Maguire K, Cervi E, Kaski J, Perez Tome M, Pantazis A, Elliott P, Lambiase P, Segal O. ORAL ABSTRACTS (3)EP & Ablation31LEFT ATRIAL POSTERIOR WALL ISOLATION (THE “BOX LESION PATTERN”) IN THE TREATMENT OF ATRIAL FIBRILLATION: A SINGLE CENTRE EXPERIENCE32DAY CASE CRYOBLATION (CRYO) FOR PAROXYSMAL ATRIAL FIBRILLATION (pAF) IN THE DISTRICT GENERAL HOSPITAL IS SAFE AND EFFECTIVE IF DONE IN HIGH VOLUME WITH EXPERIENCED OPERATORS33ABLATION INDEX-GUIDED PULMONARY VEIN ISOLATION FOR ATRIAL FIBRILLATION MAY IMPROVE CLINICAL OUTCOMES IN COMPARISON TO CONTACT FORCE-GUIDED ABLATION34THE PROCEDURAL COMPLICATION RATES AND SHORT-TERM SUCCESS RATES OF THORACOSCOPIC AF ABLATION DURING THE INSTITUTIONAL LEARNING CURVE35INITIAL PROCEDURAL RESULTS FROM DDRAMATIC-SVT STUDY: DD MECHANISM IDENTIFICATION AND LOCALISATION USING DIPOLE DENSITY MAPPING TO GUIDE ABLATION STRATEGY36MORBIDITY AND MORTALITY IN MIDDLE-AGED INDIVIDUALS WITH ATRIAL FIBRILLATION: UK BIOBANK DATAClinical EP37THE GM AHSN AF LANDSCAPE TOOL: A SHARED PUBLIC DATA PLATFORM TO PROMOTE QUALITY IMPROVEMENTS AND IDENTIFY OPPORTUNITIES TO PREVENT AF-RELATED STROKE IN THE DEVOLVED GREATER MANCHESTER HEALTH SYSTEM38REAL WORLD PERSISTENCE, ADHERENCE AND SWITCH-OVER ACROSS ANTICOAGULANTS IN ATRIAL FIBRILLATION-A NATIONAL POPULATION-BASED STUDY39ORTHOSTATIC HYPOTENSION AND ATRIAL FIBRILLATION40PREVALENCE OF SHORT QT AND CRITERIA OF SEVERITY IN A YOUNG ASYMPTOMATIC COHORT41SURFACE ELECTROCARDIOGRAPHIC FEATURES AND PREVALENCE OF ARRHYTHMIAS IN PAEDIATRIC FRIEDREICH'S ATAXIA42RISK STRATIFICATION OF TYPE 1 MYOTONIC DYSTROPHY: IS THE ECG ACCURATE ENOUGH TO SELECT PATIENTS AT RISK OF BRADYARRHYTHMIC EVENTS? Europace 2016. [DOI: 10.1093/europace/euw272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
30
|
Dulz S, Wagenfeld L, Nickel M, Richard G, Schwartz R, Bartsch U, Kohlschütter A, Schulz A. Novel morphological macular findings in juvenile CLN3 disease. Br J Ophthalmol 2015; 100:824-8. [PMID: 26486417 DOI: 10.1136/bjophthalmol-2015-307320] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2015] [Accepted: 09/25/2015] [Indexed: 11/03/2022]
Abstract
AIMS Juvenile CLN3 disease, one of the most common forms of a group of lysosomal storage diseases called neuronal ceroid lipofuscinoses (NCLs), is a progressive neurodegenerative disorder with initial visual deterioration. The objective of this study was to analyse the retinal phenotype of patients with CLN3 disease with the help of recent ophthalmic imaging modalities to distinguish CLN3 disease from other inherited retinal dystrophies. METHODS Patients underwent ophthalmic evaluations, including anterior and posterior segment examinations, optical coherence tomography, fundus autofluorescence, near infrared imaging and fundus photography. Patients were also assessed according to the Hamburg juvenile NCL (JNCL) score. Each ophthalmic finding was assessed by three independent examiners and assigned to a clinical severity score. RESULTS 22 eyes of 11 patients were included. The mean age at examination was 14.4 years (range 11.8-26.4 years), with an average age at initial diagnosis of 8 years (range 4.5-11 years). The mean Hamburg JNCL score was 7.3 (range 0-13). All patients showed a specific macular striation pattern on optical coherence tomography that was independent of age and progression of the disease. Other previously described retinal features of CLN3 disease were classified into four severity grades. CONCLUSIONS This study represents the first prospective observational case series documenting retinal abnormalities in CLN3 disease with the aid of the spectral domain optical coherence tomography. The major finding was a characteristic, striated macular pattern in all patients studied. Particularly in early disease cases, macular striae can potentially help to discriminate CLN3 disease from other inherited forms of retinitis pigmentosa.
Collapse
Affiliation(s)
- S Dulz
- Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - L Wagenfeld
- Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - M Nickel
- University Children's Hospital, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - G Richard
- Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - R Schwartz
- Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - U Bartsch
- Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - A Kohlschütter
- University Children's Hospital, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - A Schulz
- University Children's Hospital, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| |
Collapse
|
31
|
|
32
|
Shih K, Patel M, Butowski N, Bacha J, Brown D, Garner W, Steino A, Schwartz R, Kanekal S, Lopez L, Burris HA. AT-53 * PHASE I/II STUDY OF DIANHYDROGALACTITOL IN PATIENTS WITH RECURRENT MALIGNANT GLIOBLASTOMA MULTIFORME (GBM). Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou237.52] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
33
|
Ip EH, Zhang Q, Schwartz R, Tooze J, Leng X, Han H, Williamson DA. Multi-profile hidden Markov model for mood, dietary intake, and physical activity in an intervention study of childhood obesity. Stat Med 2013; 32:3314-31. [PMID: 23322318 PMCID: PMC3710544 DOI: 10.1002/sim.5719] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2011] [Revised: 11/23/2012] [Accepted: 12/03/2012] [Indexed: 11/08/2022]
Abstract
Motivated by an application to childhood obesity data in a clinical trial, this paper describes a multi-profile hidden Markov model (HMM) that uses several temporal chains of measures respectively related to psychosocial attributes, dietary intake, and energy expenditure behaviors of adolescents in a school setting. Using these psychological and behavioral profiles, the model delineates health states from the longitudinal data set. Furthermore, a two-level regression model that takes into account the clustering effects of students within school is used to assess the effects of school-based and community-based interventions and other risk factors on the transition between health states over time. The results from our study suggest that female students tend to decrease their physical activities despite a high level of anxiety about weight. The finding is consistent across intervention and control arms.
Collapse
Affiliation(s)
- E H Ip
- Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA.
| | | | | | | | | | | | | |
Collapse
|
34
|
Furuse M, Miyatake SI, Miyata T, Yoritsune E, Kawabata S, Kuroiwa T, Karajannis MA, Fisher MJ, Milla SS, Cohen KJ, Legault G, Wisoff JH, Harter DH, Hartnett E, Merkelson A, Bloom MC, Dhall G, Jones D, Korshunov A, Pfister S, Eberhart CG, Zagzag D, Allen JC, Chinot O, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, Hilton M, Abrey L, Cloughesy T, Field KM, Simes J, Nowak AK, Hovey E, Wheeler H, Cher L, Brown C, Livingstone A, Sawkins K, Rosenthal MA, McCrea HJ, Kesavabhotla K, Boockvar J, Kleinberg L, Blakeley J, Mikkelsen T, Stevens G, Ye X, Ryu S, Desideri S, Desai B, Giranda V, Grossman S, Badruddoja MA, Pazzi M, Stea B, Lefferts P, Contreras N, Wallen K, Shah R, Rance N, Schroeder K, Sanan A, Kut C, Raza S, Liang W, Abutaleb A, Xi J, Mavadia J, Ye X, Guerrero-Cazares H, McVeigh E, Li X, Quinones-Hinojosa A, Sloan AE, Reese J, Rogers LR, Embree H, Lazarus HM, Fung H, Kane D, Dropulic B, Gerson SL, Tsung GE, Green SD, Lai A, Green RM, Filka E, Cloughesy TF, Nghiemphu PL, Saito R, Yamashita Y, Sonoda Y, Kanamori M, Kumabe T, Tominaga T, Mohammadi AM, Chao ST, Peereboom DM, Barnett GH, Suh JH, Brewer C, Vogelbaum MA, Desjardins A, Peters KB, Herndon JE, Bailey LA, Alderson LM, Ranjan T, Sampson JH, Friedman AH, Bigner DD, Friedman HS, Vredenburgh JJ, Kaley TJ, Pentsova E, Omuro A, Mellinghoff I, Nolan C, Gavrilovic I, DeAngelis LM, Holland E, Lacouture ME, Ludwig E, Lassman AB, Shih KC, Bacha J, Brown DM, Garner WJ, Schwartz R, Burris HA, Shih K, Rosenblatt P, Chowdhary S, Weir A, Shepard G, Shastry M, Griner P, Hainsworth J, Sloan AE, Nock CJ, Kerstetter A, Supko J, Ye X, Barnholtz-Sloan JS, Miller R, Rich J, Takebe N, Prados M, Grossman S. CLIN-ONGOING CLINICAL TRIALS. Neuro Oncol 2012; 14:vi101-vi105. [PMCID: PMC3488786 DOI: 10.1093/neuonc/nos232] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/24/2023] Open
|
35
|
Behling E, Carraro J, Schwartz R. 1155 Comparison of Nutritional Status Obtained by Anthopometry and Bioelectrical Impedance in Children and Adolescents Submitted to Chemotherapy in a Hospital in Southern Brazil. Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)71751-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
36
|
Resnicow K, Mcmaster F, Woolford S, Slora E, Bocian A, Harris D, Drehmer J, Wasserman R, Schwartz R, Myers E, Foster J, Snetselaar L, Hollinger D, Smith K. Study design and baseline description of the BMI2 trial: reducing paediatric obesity in primary care practices. Pediatr Obes 2012; 7:3-15. [PMID: 22434735 PMCID: PMC5427511 DOI: 10.1111/j.2047-6310.2011.00001.x] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2011] [Revised: 08/01/2011] [Accepted: 08/29/2011] [Indexed: 02/06/2023]
Abstract
OBJECTIVES This study will test the efficacy of motivational interviewing (MI) conducted by primary care providers and dieticians among children ages 2-8 years old with a body mass index (BMI) ≥ 85th and ≤ 97th percentile. METHODS Forty-two practices from the American Academy of Pediatrics, Pediatric Research in Office Settings Network were assigned to one of three groups. Group 1 (usual care) measures BMI percentile at baseline, and at 1- and 2-year follow-ups and receives standard health education materials. Group 2 providers deliver three proactive MI counselling sessions with a parent of the index child in Year 1 and one additional 'booster' visit in Year 2. Group 3 adds six MI counselling sessions from a trained dietician. The primary outcome is the child's BMI percentile at 2-year follow-up. Secondary outcomes include parent report of the child's screen time, physical activity, intake of fruits and vegetables, and sugar-sweetened beverages. RESULTS We enrolled 633 eligible children whose mean BMI percentile was 92.0 and mean age of 5.1. The cohort was 57% female. Almost 70% of parents reported a household income of ≥ $40,000 per year, and 39% had at least a college education. The cohort was 63% white, 23% Hispanic, 7% black and 7% Asian. Parent self-reported confidence that their child will achieve a healthy weight was on average an 8 (out of 10). CONCLUSION To date, several aspects of the study can inform similar efforts including our ability to use volunteer clinicians to recruit participants and their willingness to dedicate their time, without pay, to receive training in MI.
Collapse
Affiliation(s)
- K. Resnicow
- Department of Health Behavior & Health Education, University of Michigan, Ann Arbor, MI, USA
| | - F. Mcmaster
- Department of Health Behavior & Health Education, University of Michigan, Ann Arbor, MI, USA
| | - S. Woolford
- Child Health Evaluation and Research Unit (CHEAR), University of Michigan, Ann Arbor, MI, USA
| | - E. Slora
- Pediatric Research in Office Settings (PROS), American Academy of Pediatrics, Elk Grove Village, IL, USA
| | - A. Bocian
- Pediatric Research in Office Settings (PROS), American Academy of Pediatrics, Elk Grove Village, IL, USA
| | - D. Harris
- Pediatric Research in Office Settings (PROS), American Academy of Pediatrics, Elk Grove Village, IL, USA
| | - J. Drehmer
- Pediatric Research in Office Settings (PROS), American Academy of Pediatrics, Elk Grove Village, IL, USA
| | - R. Wasserman
- Pediatric Research in Office Settings (PROS), American Academy of Pediatrics, Elk Grove Village, IL, USA
,Department of Pediatrics, University of Vermont, Burlington, VA, USA
| | - R. Schwartz
- Department of Pediatrics, Wake Forest University, Winston-Salem, NC, USA
| | - E. Myers
- American Dietetic Association, Chicago, IL, USA
| | - J. Foster
- American Dietetic Association, Chicago, IL, USA
| | - L. Snetselaar
- College of Public Health, University of Iowa, Iowa City, IA, USA
| | - D. Hollinger
- College of Public Health, University of Iowa, Iowa City, IA, USA
| | - K. Smith
- College of Public Health, University of Iowa, Iowa City, IA, USA
| |
Collapse
|
37
|
Kalet AL, Song HS, Sarpel U, Schwartz R, Brenner J, Ark TK, Plass J. Just enough, but not too much interactivity leads to better clinical skills performance after a computer assisted learning module. Med Teach 2012; 34:833-9. [PMID: 22917265 PMCID: PMC3826788 DOI: 10.3109/0142159x.2012.706727] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
BACKGROUND Well-designed computer-assisted instruction (CAI) can potentially transform medical education. Yet little is known about whether specific design features such as direct manipulation of the content yield meaningful gains in clinical learning. We designed three versions of a multimedia module on the abdominal exam incorporating different types of interactivity. METHODS As part of their physical diagnosis course, 162 second-year medical students were randomly assigned (1:1:1) to Watch, Click or Drag versions of the abdominal exam module. First, students' prior knowledge, spatial ability, and prior experience with abdominal exams were assessed. After using the module, students took a posttest; demonstrated the abdominal exam on a standardized patient; and wrote structured notes of their findings. RESULTS Data from 143 students were analyzed. Baseline measures showed no differences among groups regarding prior knowledge, experience, or spatial ability. Overall there was no difference in knowledge across groups. However, physical exam scores were significantly higher for students in the Click group. CONCLUSIONS A mid-range level of behavioral interactivity was associated with small to moderate improvements in performance of clinical skills. These improvements were likely mediated by enhanced engagement with the material, within the bounds of learners' cognitive capacity. These findings have implications for the design of CAI materials to teach procedural skills.
Collapse
Affiliation(s)
- A L Kalet
- Division of Educational Informatics, New York University School of Medicine, NY, USA.
| | | | | | | | | | | | | |
Collapse
|
38
|
Lyon M, Schwartz R, Lerner B, Wedmore I, Slane M. 280 Use of the Abdominal Aortic Tourniquet to Reduce or Eliminate Flow in the Common Femoral Artery in Human Subjects. Ann Emerg Med 2011. [DOI: 10.1016/j.annemergmed.2011.06.310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
39
|
Betz M, Schwartz R, Valley M, Lowenstein S. 165 Driving Patterns Among Older Emergency Department Patients. Ann Emerg Med 2011. [DOI: 10.1016/j.annemergmed.2011.06.193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
40
|
Fussenegger M, Fassnacht D, Schwartz R, Zanghi JA, Graf M, Bailey JE, Pörtner R. Regulated overexpression of the survival factor bcl-2 in CHO cells increases viable cell density in batch culture and decreases DNA release in extended fixed-bed cultivation. Cytotechnology 2011; 32:45-61. [PMID: 19002966 DOI: 10.1023/a:1008168522385] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Using multicistronic expression technology we generated a stable Chinese hamster ovary (CHO) cell line (MG12) expressing a model secreted heterologous glycoprotein, the secreted form of the human placental alkaline phosphatase (SEAP), and bcl-2, best known as an apoptosis inhibitor, in a tetracycline-repressible dicistronic configuration. In batch cultivations in serum-containing medium, MG12 cells reached twice the final viable cell density when Bcl-2 was overexpressed (in the absence oftetracycline) compared to MG12 populations culturedunder tetracycline-containing conditions (bcl-2repressed). However, bcl-2-expressing MG12 cellsshowed no significant retardation of the decline phasecompared to batch cultures in which the dicistronicexpression unit was repressed.Genetic linkage of bcl-2 expression with the reporter protein SEAP in our multicistronic construct allowed online monitoring of Bcl-2 expression over an extended, multistage fixed-bed bioreactor cultivation. The cloned multicistronic expression unit proved to be stable over a 100 day bioreactor run. CHO MG12 cells in the fixed-bed reactor showed a drastic decrease in the release of DNA into the culture supernatant under conditions of reduced tetracycline (and hencederepressed SEAP and bcl-2 overexpression). This observation indicated enhanced robustness associated with bcl-2 overexpression, similar to recent findings for constitutive Bcl-2-overexpressing hybridoma cells under the same bioprocess conditions. These findings indicate, in these serum-containing CHO cell cultures, that overexpression of Bcl-2 results in desirable modifications in culture physiology.
Collapse
Affiliation(s)
- M Fussenegger
- Institute of Biotechnology, ETH Zürich, CH-8093, Zürich, Switzerland
| | | | | | | | | | | | | |
Collapse
|
41
|
Bamforth SD, MacDonald ST, Braganca J, Chen CM, Broadbent C, Schneider JE, Schwartz R, Bhattacharya S. 137 A cited2->Vegfa pathway couples myocardial and coronary vascular growth in the developing mouse heart. Heart 2011. [DOI: 10.1136/heartjnl-2011-300198.137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
42
|
Dorff TB, Schuckman A, Schwartz R, Danenberg K, Ma Y, Cai J, Rashad S, Skinner EC, Quinn DI, Pinski JK. Molecular markers and outcomes in penile squamous cancer (PSC). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e15016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
43
|
Dorff TB, Schwartz R, Ma Y, Cai J, Bulbul A, Skinner EC, Quinn DI, Danenberg K, Schuckman A. EGFR, TS, and ERCC1 expression in penile squamous cancer (PSC). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.7_suppl.219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
219 Background: PSC is an aggressive disease with devastating consequences. While near-universal EGFR overexpression has been documented, little is known about its clinical implications, and the potential role of KRAS mutations has not been described. In other tumor types, ERCC1 and TS expression are associated with response to platinum and 5FU chemotherapy, but have not yet been evaluated in PSC. Methods: After IRB approval, 28 PSC patients treated at LAC-USC were identified with tumor specimens available. Testing for EGFR, TS, and ERCC1 expression relative to internal standard gene was performed by real-time RT-PCR and correlated with clinical features. Results: The median age was 45 (30-78). There were 2 Black, 1 Asian, 1 White, and 15 Hispanic men; 9 had unspecified race. T stages included 4 Tis, 6 T1, 17 T2, and 9 T3; 11 men had lymph node (LN) involvement. No KRAS mutations were identified. EGFR had the highest relative expression (median 4.65, range 1.6-44.2), followed by TS (median 1.69, range 0.49-4.69); ERCC1 overexpression was rare (median 0.54, range 0.21-1.29). Higher EGFR expression was significantly associated with poor differentiation (median 12.5 compared to 3.6 for moderate/well differentiated tumors) on continuous (p=0.03 by Mann Whitney) and cut-point analysis using >7 (two- sided p=0.03 by Fisher's exact test) but did not correlate with stage. Stage > T2 showed a trend toward higher risk of LN involvement (p=0.06 by chi square). There was no correlation between differentiation and stage, and no significant correlation for ERCC1 or TS with grade or stage. Conclusions: EGFR overexpression is common in PSC and correlates with tumor grade but not stage, suggesting it may be important for disease progression. The absence of KRAS mutations may portend responsiveness to EGFR- targeted therapy based on experience in other tumors. Low ERCC1 as an association with platinum response will be explored in an expanded cohort. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- T. B. Dorff
- Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, CA; Keck School of Medicine of the University of Southern California, Los Angeles, CA; Los Angeles County and University of Southern California Medical Center, Los Angeles, CA; University of Southern California Institute of Urology, Los Angeles, CA; Response Genetics, Los Angeles, CA
| | - R. Schwartz
- Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, CA; Keck School of Medicine of the University of Southern California, Los Angeles, CA; Los Angeles County and University of Southern California Medical Center, Los Angeles, CA; University of Southern California Institute of Urology, Los Angeles, CA; Response Genetics, Los Angeles, CA
| | - Y. Ma
- Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, CA; Keck School of Medicine of the University of Southern California, Los Angeles, CA; Los Angeles County and University of Southern California Medical Center, Los Angeles, CA; University of Southern California Institute of Urology, Los Angeles, CA; Response Genetics, Los Angeles, CA
| | - J. Cai
- Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, CA; Keck School of Medicine of the University of Southern California, Los Angeles, CA; Los Angeles County and University of Southern California Medical Center, Los Angeles, CA; University of Southern California Institute of Urology, Los Angeles, CA; Response Genetics, Los Angeles, CA
| | - A. Bulbul
- Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, CA; Keck School of Medicine of the University of Southern California, Los Angeles, CA; Los Angeles County and University of Southern California Medical Center, Los Angeles, CA; University of Southern California Institute of Urology, Los Angeles, CA; Response Genetics, Los Angeles, CA
| | - E. C. Skinner
- Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, CA; Keck School of Medicine of the University of Southern California, Los Angeles, CA; Los Angeles County and University of Southern California Medical Center, Los Angeles, CA; University of Southern California Institute of Urology, Los Angeles, CA; Response Genetics, Los Angeles, CA
| | - D. I. Quinn
- Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, CA; Keck School of Medicine of the University of Southern California, Los Angeles, CA; Los Angeles County and University of Southern California Medical Center, Los Angeles, CA; University of Southern California Institute of Urology, Los Angeles, CA; Response Genetics, Los Angeles, CA
| | - K. Danenberg
- Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, CA; Keck School of Medicine of the University of Southern California, Los Angeles, CA; Los Angeles County and University of Southern California Medical Center, Los Angeles, CA; University of Southern California Institute of Urology, Los Angeles, CA; Response Genetics, Los Angeles, CA
| | - A. Schuckman
- Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, CA; Keck School of Medicine of the University of Southern California, Los Angeles, CA; Los Angeles County and University of Southern California Medical Center, Los Angeles, CA; University of Southern California Institute of Urology, Los Angeles, CA; Response Genetics, Los Angeles, CA
| |
Collapse
|
44
|
Quistberg DA, Lozano P, Mack CD, Schwartz R, Ebel BE. A comparison of self-report and direct observation of booster seat use in Latino families. Inj Prev 2010; 16:225-9. [DOI: 10.1136/ip.2009.025338] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
45
|
Bernard SA, Valgus J, Jarr S, Rice M, Schwartz R. Use of a pharmacist/nurse model for the delivery of supportive care in adult oncology clinics at the University of North Carolina Hospital. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.9166] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
46
|
Greenfield E, McManus J, Cooke W, Pittman D, Shiver S, Beatty J, Croushorn J, Schwartz R. 201: Safety and Efficacy of a Novel Abdominal Aortic Tourniquet Device for the Control of Pelvic and Lower Extremity Hemorrhage. Ann Emerg Med 2009. [DOI: 10.1016/j.annemergmed.2009.06.230] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
47
|
Korz R, Schwartz R. Fall 1122. Dtsch Med Wochenschr 2009. [DOI: 10.1055/s-0029-1236678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
48
|
Jagannath S, Vij R, Stewart K, Somlo G, Jakubowiak A, Trudel S, Schwartz R, Siegel D, Kunkel L. Final results of PX-171–003-A0, part 1 of an open-label, single-arm, phase II study of carfilzomib (CFZ) in patients (pts) with relapsed and refractory multiple myeloma (MM). J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.8504] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8504 Background: CFZ is a novel proteasome inhibitor of the epoxyketone class that exhibits a high level of proteasome selectivityand demonstrates antitumor activity in bortezomib (BTZ)-resistant MM pts in phase I studies. Methods: PX-171–003-A0 was an open-label, multicenter study that enrolled MM pts who relapsed from >2 prior therapies, failed BTZ and at least 1 immunomodulatory agent [thalidomide (THAL) or lenalidomide (LEN)], and were refractory to last treatment [progressing on or within 60 d of last therapy or <25% response to last therapy]. Pts received CFZ 20 mg/m2 IV d 1, 2, 8, 9, 15 and 16 every 28 d for up to 12 cycles (C). Clinical benefit response (CBR) was defined as MR or better. Results: 46 pts were enrolled, including 78% with progression on or within 60 d of last therapy and 22% with no response to last therapy. 39 pts completed at least 1 C of CFZ, had measurable M-protein, and were evaluable for response. Median prior therapies was 5 (range 2–15). 100% of pts received prior BTZ, 91% prior THAL, 89% prior LEN, and 83% prior stem cell transplant (SCT) and all had failed combinations including anthracyclines (80%) and/or alkylating agents (94%). Pts received a median of 3 C (range 1–12); 13 pts completed ≥6 C. CBR was 26% (10/39 eval pts), including 5 pts achieving PR and 5 pts achieving MR. 5 BTZ-refractory pts achieved MR or PR. Median TTP was 6.2 mo, the median DOR for the MR + PR was 7.4 mo. 8/10 pts achieved response during C1. 16 additional pts achieved SD for at least 6 wks. The most common adverse events were fatigue, anemia, thrombocytopenia, nausea, upper respiratory infection, increased creatinine and diarrhea. Peripheral neuropathy occured in < 10% of pts with 1 Gr 3 in a pt with pre-existing Gr 2. Conclusions: Single-agent CFZ achieved a TTP of > 6 mo in relapsed and refractory MM pts who failed available therapies. 26% of patients had at least an MR and median duration of >7 mo with this steroid- and anthracycline-sparing regimen. CFZ toxicities were manageable and importantly, exacerbation of pre-existing PN was rare. The study has been expanded to enroll an additional 250 pts in this unmet medical need population at an escalated dose, and treatment has been extended beyond a year. [Table: see text]
Collapse
Affiliation(s)
- S. Jagannath
- St. Vincent's Comprehensive Cancer Center, New York, NY; Washington University School of Medicine, St. Louis, MO; Mayo Clinic, Scottsdale, AZ; City of Hope, Duarte, CA; University of Michigan, Ann Arbor, MI; Princess Margaret Hospital, Toronto, ON, Canada; Proteolix, Inc., South San Francisco, CA; Hackensack University Medical Center, Hackensack, NJ
| | - R. Vij
- St. Vincent's Comprehensive Cancer Center, New York, NY; Washington University School of Medicine, St. Louis, MO; Mayo Clinic, Scottsdale, AZ; City of Hope, Duarte, CA; University of Michigan, Ann Arbor, MI; Princess Margaret Hospital, Toronto, ON, Canada; Proteolix, Inc., South San Francisco, CA; Hackensack University Medical Center, Hackensack, NJ
| | - K. Stewart
- St. Vincent's Comprehensive Cancer Center, New York, NY; Washington University School of Medicine, St. Louis, MO; Mayo Clinic, Scottsdale, AZ; City of Hope, Duarte, CA; University of Michigan, Ann Arbor, MI; Princess Margaret Hospital, Toronto, ON, Canada; Proteolix, Inc., South San Francisco, CA; Hackensack University Medical Center, Hackensack, NJ
| | - G. Somlo
- St. Vincent's Comprehensive Cancer Center, New York, NY; Washington University School of Medicine, St. Louis, MO; Mayo Clinic, Scottsdale, AZ; City of Hope, Duarte, CA; University of Michigan, Ann Arbor, MI; Princess Margaret Hospital, Toronto, ON, Canada; Proteolix, Inc., South San Francisco, CA; Hackensack University Medical Center, Hackensack, NJ
| | - A. Jakubowiak
- St. Vincent's Comprehensive Cancer Center, New York, NY; Washington University School of Medicine, St. Louis, MO; Mayo Clinic, Scottsdale, AZ; City of Hope, Duarte, CA; University of Michigan, Ann Arbor, MI; Princess Margaret Hospital, Toronto, ON, Canada; Proteolix, Inc., South San Francisco, CA; Hackensack University Medical Center, Hackensack, NJ
| | - S. Trudel
- St. Vincent's Comprehensive Cancer Center, New York, NY; Washington University School of Medicine, St. Louis, MO; Mayo Clinic, Scottsdale, AZ; City of Hope, Duarte, CA; University of Michigan, Ann Arbor, MI; Princess Margaret Hospital, Toronto, ON, Canada; Proteolix, Inc., South San Francisco, CA; Hackensack University Medical Center, Hackensack, NJ
| | - R. Schwartz
- St. Vincent's Comprehensive Cancer Center, New York, NY; Washington University School of Medicine, St. Louis, MO; Mayo Clinic, Scottsdale, AZ; City of Hope, Duarte, CA; University of Michigan, Ann Arbor, MI; Princess Margaret Hospital, Toronto, ON, Canada; Proteolix, Inc., South San Francisco, CA; Hackensack University Medical Center, Hackensack, NJ
| | - D. Siegel
- St. Vincent's Comprehensive Cancer Center, New York, NY; Washington University School of Medicine, St. Louis, MO; Mayo Clinic, Scottsdale, AZ; City of Hope, Duarte, CA; University of Michigan, Ann Arbor, MI; Princess Margaret Hospital, Toronto, ON, Canada; Proteolix, Inc., South San Francisco, CA; Hackensack University Medical Center, Hackensack, NJ
| | - L. Kunkel
- St. Vincent's Comprehensive Cancer Center, New York, NY; Washington University School of Medicine, St. Louis, MO; Mayo Clinic, Scottsdale, AZ; City of Hope, Duarte, CA; University of Michigan, Ann Arbor, MI; Princess Margaret Hospital, Toronto, ON, Canada; Proteolix, Inc., South San Francisco, CA; Hackensack University Medical Center, Hackensack, NJ
| |
Collapse
|
49
|
Schwartz R, Mulkern R, Vajapeyam S, Kacher DF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2009; 30:E19; author reply E20. [PMID: 19208904 DOI: 10.3174/ajnr.a1285] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
50
|
Jagannath S, Vij R, Stewart AK, Somlo G, Jakubowiak A, Reiman T, Trudel S, Taylor J, Fuhrman D, Cruickshank S, Schwartz R, Kunkel L, Siegel D. A377 Phase II Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (PX-171-003). ACTA ACUST UNITED AC 2009. [DOI: 10.1016/s1557-9190(11)70562-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|